Robert Beauchamp
Principal Investigator
Last active: 10/31/2018

  1. Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors. Li JQ, Wu F, Masaki T, Kubo A, Fujita J, Dixon DA, Beauchamp RD, Ishida T, Kuriyama S, Imaida K (2004) Int J Oncol 25(1): 87-95
    › Primary publication · 15201993 (PubMed)
  2. Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. Dixon DA, Balch GC, Kedersha N, Anderson P, Zimmerman GA, Beauchamp RD, Prescott SM (2003) J Exp Med 198(3): 475-81
    › Primary publication · 12885872 (PubMed) · PMC2194089 (PubMed Central)
  3. Over-expression of cyclin D1 regulates Cdk4 protein synthesis. Parker MA, Deane NG, Thompson EA, Whitehead RH, Mithani SK, Washington MK, Datta PK, Dixon DA, Beauchamp RD (2003) Cell Prolif 36(6): 347-60
    › Primary publication · 14710852 (PubMed)
  4. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Balch GC, Mithani SK, Richards KR, Beauchamp RD, Kelley MC (2003) Ann Surg Oncol 10(6): 616-21
    › Primary publication · 12839845 (PubMed)
  5. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions. Berger DH, O'Mahony CA, Sheng H, Shao J, Albo D, DuBois RN, Beauchamp RD (2003) Surgery 133(5): 568-79
    › Primary publication · 12773985 (PubMed)
  6. Dysregulation of E-cadherin by oncogenic Ras in intestinal epithelial cells is blocked by inhibiting MAP kinase. Schmidt CR, Washington MK, Gi YJ, Coffey RJ, Beauchamp RD, Pearson AS (2003) Am J Surg 186(5): 426-30
    › Primary publication · 14599601 (PubMed)
  7. A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization. Ahmed A, Thompson J, Emiliusen L, Murphy S, Beauchamp RD, Suzuki K, Alemany R, Harrington K, Vile RG (2003) Nat Biotechnol 21(7): 771-7
    › Primary publication · 12794639 (PubMed)
  8. Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats. Roman CD, Choy H, Nanney L, Riordan C, Parman K, Johnson D, Beauchamp RD (2002) J Surg Res 105(1): 43-7
    › Primary publication · 12069500 (PubMed)
  9. Resistance to transforming growth factor-beta occurs in the presence of normal Smad activation. Berger DH, Feng XH, Yao J, Saha D, Beauchamp RD, Lin X (2002) Surgery 132(2): 310-6
    › Primary publication · 12219028 (PubMed)
  10. Operative technique for safe pulmonary lobectomy in Sprague-Dawley rats. Roman CD, Hanley GA, Beauchamp RD (2002) Contemp Top Lab Anim Sci 41(2): 28-30
    › Primary publication · 11958600 (PubMed)